BLOG

Sunday, September 30, 2018

Dr Reddy's Laboratories terminates Armis Biopharma's investigation license

DFA-02 has been studied in several phase 1 and 2 clinical studies

from Companies https://ift.tt/2IulFwa
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...